Work in Saccharomyces cerevisiae and Cryptococcus neoformans suggests that caspofungin could interact with the calcineurin pathway. We examined the in vitro interaction of caspofungin with calcineurin inhibitors (FK506, cyclosporin, FK520 and L685,818) and the TOR inhibitor rapamycin in 13 isolates of Aspergillus species. Caspofungin activity was enhanced by calcineurin/TOR inhibitors for all Aspergillus isolates studied. Further investigation of this pathway is warranted.
Introduction
Caspofungin (CAS), a novel echinocandin, inhibits 1,3-β-Dglucan synthase, a fungus-specific enzyme that is critical for cell-wall biosynthesis. 1, 2 Against Aspergillus species, CAS displays a complex pattern of growth inhibition that results in death of actively growing hyphal tips. 3 Little is known, however, about the mechanisms regulating CAS action in Aspergillus spp. 4 Genetic studies in Saccharomyces cerevisiae have shown that glucan synthase is composed of two subunits: a putative catalytic subunit encoded by the genes FKS1 and FKS2 and a regulatory subunit composed of a GTPbound protein encoded by RHO1. 2 Interaction between CAS and the evolutionarily conserved calcineurin pathway is suggested by the observation that mutations in FKS1, the putative target of CAS activity, result in hypersensitivity of S. cerevisiae to the immunosuppressive agent FK506, 2 whose action is mediated through inhibition of the phosphatase calcineurin. 5 In addition, the second FKS homologue, FKS2, is regulated by calcineurin. 2 Furthermore, FK506 and L685,818, a non-immunosuppressive analogue of FK506, 6, 7 have demonstrated synergic interactions with CAS against Cryptococcus neoformans, a fungus with inherent resistance to CAS. 8 
Materials and methods
We evaluated the in vitro interaction between CAS and several structurally unrelated inhibitors of the calcineurin pathway (FK506, cyclosporin, FK520 and L685,818) and rapamycin, a potent immunosuppressive inhibitor of TOR kinase, against Aspergillus spp., for which CAS demonstrates a lack of complete growth inhibition in vitro. Both FK506 and rapamycin form complexes with the immunophilin protein FKBP12. 9 5 mg/mL in DMSO) and rapamycin (Sigma Chemicals; 2 µg/mL in DMSO) were prepared and stored at -70°C until use. Disc diffusion testing was carried out on YAG plates (0.5% yeast extract, 1% dextrose, 1.5% agar) by plating a standardized suspension (1 × 10 7 conidia/mL) of Aspergillus isolates. After plates were allowed to dry, three sterile 1/4 inch paper discs (Schleicher and Schuell, Keene, NH, USA) were placed on the agar surface and inoculated (10 µL) with 1 µg of CAS, 1 µg of one of the calcineurin inhibitors (FK506, cyclosporin, FK520 and L685,818), rapamycin or the combination of 1 µg of CAS with 1 µg of one of the aforementioned inhibitors placed on the same disc. Because of the lack of significant activity of the combination of L685,818 with CAS when 1 µg of L685,818 was put on the disc, 2 µg of L685,818 was used either alone or in combination with 1 µg of CAS. Plates were then incubated for 48 h at 37°C. The radius of the zone of growth inhibition was measured using a micrometer at 24 and 48 h at 37°C. Measurements were compared by Kruskal-Wallis One Way Analysis of Variance on Ranks. Differences between CAS and CAS/inhibitor combinations were further analysed post-hoc by Tukey's test for multiple comparisons. DMSO (1 µg of 100% solution) served as the vehicle control. The experiments were repeated three times.
Results
A positive interaction between CAS in combination with any of the calcineurin inhibitors or rapamycin was observed in all A. fumigatus isolates tested (Figure 1 ). The A. fumigatus isolates tested showed strain-dependent differences; however, consistent enhancement of the activity of CAS followed by exposure to the calcineurin inhibitors or rapamycin was seen in all isolates. There was a time-dependent effect of the combination as the observed attenuation of growth was best appreciated after 48 h of incubation ( Table 1 ). The combination of CAS with the non-immunosuppressive analogue L685,818 had the least antifungal activity. Growth attenuation was barely perceptible when 1 µg of L685,818 and 1 µg of CAS were put on the disc (Table 1 ). All calcineurin inhibitors demonstrated little or no intrinsic antifungal activity when used alone (Figure 1 ). The combinations resulted in attenuation of growth but did not produce a clear zone of inhibition. The combination of CAS with either FK506 or rapamycin exerted the most significant effect ( Table 1 ). The combination of CAS with L685,818 chequerboard method did not result in a fungicidal effect at several concentrations of CAS or L685,818 used (data not shown). The combination of CAS with the calcineurin inhibitors or rapamycin resulted in a similar attenuation of growth in all isolates of A. terreus and A. flavus tested, especially after 48 h of growth (Table 2) .
Finally, the inhibition of growth seen between the calcineurin inhibitors and CAS was not specific to echinocandins, since attenuation of growth was also observed with the combination of calcineurin inhibitors (FK506 and L685,818) with other antifungals (1 µg of itraconazole/disc) or cellular growth inhibitors (1 µg of cyclohexamide/disc, 10 µL of 3% peroxide disc) (Figure 2 ).
Discussion
Our findings suggest that a functional link might exist between the calcineurin pathway and the tolerance to antifungals in Aspergillus spp. This interaction does not appear to be Aspergillus species specific. Recent evidence in Candida albicans 10 suggests that the calcineurin and TOR pathways play a conserved role in the regulation of the stress response of fungi against a variety of cellular growth inhibitors. Inhibition or down-regulation of the calcineurin or TOR pathways could decrease the threshold of deleterious effects of antifungals in moulds such as Aspergillus spp. Alternatively, other indirect mechanisms might be operative. Hence, it is possible that calcineurin/TOR pathway inhibitors affect separate, unrelated metabolic processes in Aspergillus spp., and their combination with CAS-induced inhibition of cell wall integrity results in growth arrest. For example, cyclosporin and FK506 have been reported to be toxic against A. fumigatus 6 and rapamycin has been reported to be toxic against C. albicans and C. neoformans. 11 Nevertheless, specific interactions are possible. Thus, an inhibition of the expression of the A. fumigatus FKS1 homologue 4 could occur by the combination of CAS and the calcineurin or TOR inhibitors. Since pneumocandins can be naturally detected in Aspergillus spp. themselves, 1,2 it will be interesting to examine the specific role of the calcineurin pathway in the orchestrated regulation of cell wall sensing pathways and stress response.
Although the non-immunosuppressive compound L685,818 was the least potent in its interaction with CAS, itraconazole or other cellular inhibitors, the mechanisms and the clinical utility of the observed synergy between calcineurin inhibitors and glucan synthase inhibitors needs further investigation. Preliminary clinical experience suggests that the combination of the echinocandins with some calcineurin inhibitors (tacrolimus) is well tolerated. Finally, in view of the regulation of virulence of C. neoformans by the calcineurin pathway, 5 it will be of interest to examine the virulence of A. fumigatus when exposed to combinations of novel agents targeting this and other signalling pathways. Of note, components of the 
